Iron chelation as novel treatment for lung inflammation in cystic fibrosis

Keyphrases

• Autosomal Recessive 25%
• Chelator 25%
• Chronic Inflammation 50%
• Cystic Fibrosis 100%
• Cystic Fibrosis Transmembrane Conductance Regulator 50%
• Immune Cells 25%
• Inflammatory Response 25%
• Inhalational Route 25%
• Iron Chelation 100%
• Iron Chelator 50%
• Lung 50%
• Lung Inflammation 100%
• Lung Tissue 25%
• Lung Tissue Damage 25%
• Neutrophils 75%
• Novel Treatments 100%
• Progressive Destruction 25%
• Protein Expression 25%
• Protein Function 25%
• Reactive Oxygen Species Production 50%
• Recessive Genetic Disorder 25%
• Recurrent Infection 25%
• Route of Administration 25%
• Sequester 25%

Medicine and Dentistry

• Autosomal Recessive Inheritance 25%
• Chelating Agent 25%
• Chronic Inflammation 50%
• Cystic Fibrosis 100%
• Cystic Fibrosis Transmembrane Conductance Regulator 50%
• Genetic Disorder 25%
• Immunocompetent Cell 25%
• Iron Chelating Agent 50%
• Neutrophil 75%
• Pneumonia 100%
• Protein Expression 25%
• Protein Function 25%
• Reactive Oxygen Species 50%
• Recurrent Infection 25%
• Regulator Protein 25%
• Serositis 25%
• Tissue Injury 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Chelating Agent 25%
• Chronic Inflammation 50%
• Cystic Fibrosis 100%
• Cystic Fibrosis Transmembrane Conductance Regulator 50%
• Genetic Disorder 25%
• Inflammation 25%
• Iron Chelating Agent 50%
• Pneumonia 100%
• Reactive Oxygen Metabolite 50%
• Recurrent Infection 25%
• Regulator Protein 25%
• Route of Administration 25%
• Tissue Injury 25%